Literature DB >> 34794851

Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline.

Karis Little1, María Llorián-Salvador1, Sarah Scullion1, Cristina Hernández2, Olga Simó-Servat2, Angel Del Marco3, Esmeralda Bosma4, Maria Vargas-Soria3, Maria Jose Carranza-Naval3, Tine Van Bergen5, Silvia Galbiati6, Ilaria Viganò6, Clara Alice Musi7, Reiner Schlingemann8, Jean Feyen5, Tiziana Borsello7, Gianpaolo Zerbini6, Ingeborg Klaassen4, Monica Garcia-Alloza3, Rafael Simó9, Alan W Stitt10.   

Abstract

Type 2 diabetes (T2D) is associated with multiple comorbidities, including diabetic retinopathy (DR) and cognitive decline, and T2D patients have a significantly higher risk of developing Alzheimer's disease (AD). Both DR and AD are characterized by a number of pathological mechanisms that coalesce around the neurovascular unit, including neuroinflammation and degeneration, vascular degeneration, and glial activation. Chronic hyperglycemia and insulin resistance also play a significant role, leading to activation of pathological mechanisms such as increased oxidative stress and the accumulation of advanced glycation end-products (AGEs). Understanding these common pathways and the degree to which they occur simultaneously in the brain and retina during diabetes will provide avenues to identify T2D patients at risk of cognitive decline.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Alzheimer’s disease; cognitive decline; diabetes; neurovascular unit

Mesh:

Substances:

Year:  2021        PMID: 34794851     DOI: 10.1016/j.tem.2021.10.008

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  4 in total

Review 1.  Microphysiological Neurovascular Barriers to Model the Inner Retinal Microvasculature.

Authors:  Thomas L Maurissen; Georgios Pavlou; Colette Bichsel; Roberto Villaseñor; Roger D Kamm; Héloïse Ragelle
Journal:  J Pers Med       Date:  2022-01-24

2.  HSPB8 Overexpression Ameliorates Cognitive Impairment in Diabetic Mice via Inhibiting NLRP3 Inflammation Activation.

Authors:  Yanmin Chang; Yanqing Wu; Xingjun Jiang; Jiahui Zhu; Cailin Wang; Rong Ma; Gang Li
Journal:  Oxid Med Cell Longev       Date:  2022-08-01       Impact factor: 7.310

Review 3.  New Insights into Treating Early and Advanced Stage Diabetic Retinopathy.

Authors:  Rafael Simó; Cristina Hernández
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

Review 4.  A review on contemporary nanomaterial-based therapeutics for the treatment of diabetic foot ulcers (DFUs) with special reference to the Indian scenario.

Authors:  Lakshimipriya Sethuram; John Thomas; Amitava Mukherjee; Natarajan Chandrasekaran
Journal:  Nanoscale Adv       Date:  2022-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.